Childhood acute myeloid leukaemia (AML) prognosis
AML is a life-threatening illness but the chance of long-term survival for children and young adults with AML has improved in recent years.
Children and young adults can have stronger treatments than older people, and most respond well to the treatment for AML. Everyone is different, so your child’s consultant (specialist doctor) is the best person to tell you about their individual prognosis (what’s likely to happen in the future).
Not everyone wants information about their child’s prognosis. If you don’t want to talk about it, tell your child’s healthcare team - you can change your mind at any time. The healthcare team is not allowed to talk to anyone else about it, even family members, without your permission as parent or carer. Older children will be involved in deciding what they want to know about their prognosis, and who to share that information with.
Our research impact on childhood leukaemia
Tackling childhood leukaemia is where we have some of our biggest research breakthroughs.
Worried or have questions about prognosis?
We can talk you through it and support you to have conversations with your doctor.